Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3QZH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,776
Award facts
- Contract value 100% obligated
- $3,776.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,776.39 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of December 10, 2025. The contract utilized firm fixed pricing under a non-competitive delivery order, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a single delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical support vehicle running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally.
REPATHA is a prescription medication used to treat high cholesterol and reduce cardiovascular risk. As a pharmaceutical distributor serving the federal medical supply chain, AmerisourceBergen fulfills critical pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to manage diverse medical commodities including specialty medications, vaccines, and auto-injector delivery systems across multiple therapeutic domains, supporting military and veteran healthcare systems with both brand-name and generic pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26F3QZH?
SPE2DR26F3QZH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F3QZH worth?
The government has obligated $3,776 on SPE2DR26F3QZH.
Is contract SPE2DR26F3QZH an order under another contract?
Yes. SPE2DR26F3QZH is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QZH competed?
The extent of competition for SPE2DR26F3QZH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award